# Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose

> **NCT02864472** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Age-related Macular Degeneration

## Interventions

- **PROCEDURE:** PDT
- **DRUG:** Ranibizumab
- **DRUG:** ranibizumab PRN

## Key facts

- **NCT ID:** NCT02864472
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2018-06
- **Final completion:** 2019-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864472, "Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02864472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*